Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial

Edith A. Perez, Vera J. Suman, Nancy E. Davidson, George W. Sledge, Peter A. Kaufman, Clifford A. Hudis, Silvana Martino, Julie R. Gralow, Shaker R. Dakhil, James N. Ingle, Eric P. Winer, Karen A. Gelmon, Bernard J. Gersh, Allan S. Jaffe, Richard J. Rodeheffer

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial'. Together they form a unique fingerprint.

Medicine & Life Sciences